Injecto Polymers IPO GMP Today, Price & Details
Injecto Polymers IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Injecto Polymers
Injecto Polymers is stepping into the public market through a Small and Medium Enterprise (SME) Initial Public Offering (IPO) on the BSE. The company operates in the vital polymers sector, likely involved in manufacturing or processing polymer-based products. While specific product details aren't provided, the scale of operations can be gauged from its recent financial performance, indicating a significant revenue base.
The company has reported a revenue of ₹261.85 Cr with a Profit After Tax (PAT) of ₹8.11 Cr. This translates to an Earnings Per Share (EPS) of ₹3.9. The IPO is structured entirely as a fresh issue, with the company looking to raise ₹56 Cr. This means all the proceeds will go towards the company's growth and operational needs, rather than providing an exit for existing shareholders.
In terms of competitive positioning, Injecto Polymers operates in a dynamic industry. The use of proceeds from this IPO will be crucial for its future expansion and strengthening its market presence. Investors will be keen to understand how the company plans to leverage these funds to enhance its profitability and market share within the competitive polymer landscape.
Injecto Polymers IPO — Investment Analysis
Injecto Polymers is coming to market with a price band of ₹90 to ₹100 per share. The company's trailing EPS stands at ₹3.9, which, when compared to the upper price band of ₹100, results in a Price-to-Earnings (P/E) ratio of approximately 25.64x. This valuation needs to be assessed against industry peers and the company's growth prospects. While not excessively high, it's certainly not a deep value offering, suggesting investors are paying a reasonable price for the current earnings.
Looking at the financial health, Injecto Polymers has posted revenues of ₹261.85 Cr and a PAT of ₹8.11 Cr. This indicates a net profit margin of roughly 3.1%. While the revenue figure shows a decent scale of operations, the profit margin is something to keep an eye on. Detailed segment-wise revenue and EBITDA figures would offer a clearer picture of operational efficiency, but based on the provided PAT, profitability appears modest relative to revenue.
The IPO is a 100% fresh issue, meaning all funds raised will be injected into the company for its growth initiatives. This is generally positive as it directly strengthens the company's balance sheet and potential for expansion. However, the absence of an Offer for Sale (OFS) means there's no indication of existing investor confidence through divestment. Key risks include the inherent volatility of the SME segment, potential margin pressures in the competitive polymer industry, and the execution risk associated with deploying the fresh capital effectively.
Subscription levels will be a crucial indicator of market sentiment towards Injecto Polymers. Strong participation from Qualified Institutional Buyers (QIBs) and High Net-worth Individuals (HNIs) would signal institutional confidence, while robust retail investor interest would reflect broader market appeal. Conversely, muted subscriptions could suggest investor caution regarding valuation or business fundamentals. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.
Injecto Polymers IPO — Pros & Cons
Strengths
- The company has generated a revenue of ₹261.85 Cr, showcasing a significant scale of operations. This suggests a well-established presence and customer base within its sector, which is a positive sign for potential investors.
- The IPO is structured as a 100% fresh issue, raising ₹56 Cr. This means the capital raised will directly bolster the company's balance sheet and fund future growth, rather than being used for promoter exits, which is generally beneficial for long-term value creation.
- Injecto Polymers has a reported Earnings Per Share (EPS) of ₹3.9. This indicates profitability on a per-share basis, providing a fundamental metric for investors to evaluate the company's earning power.
- The company is listed on the BSE SME platform, offering accessibility to a wider range of investors interested in small and mid-cap opportunities. This platform can provide good visibility and liquidity for growing companies.
- The lot size for the IPO is 1200 shares, with a price band of ₹90 to ₹100. This allows for a relatively accessible minimum investment for retail investors keen on participating in the IPO.
Risks
- The company's Profit After Tax (PAT) stands at ₹8.11 Cr on a revenue of ₹261.85 Cr, resulting in a net profit margin of approximately 3.1%. This relatively low margin could indicate intense competition or operational inefficiencies that might impact future profitability.
- The P/E ratio, calculated at approximately 25.64x based on the upper price band of ₹100 and an EPS of ₹3.9, might be considered on the higher side for a company with modest profit margins. Investors should carefully assess if this valuation is justified by the company's growth prospects.
- As an SME IPO, Injecto Polymers might face higher volatility and lower liquidity compared to mainboard listings. This means that while there's potential for quick gains, there's also a greater risk of sharp price corrections.
- The provided financial data is limited, with specific details on EBITDA, debt levels, and return ratios like RONW and ROCE not being readily available. This lack of comprehensive financial disclosure makes a deeper analysis of the company's financial health more challenging for investors.
- The polymer industry can be susceptible to raw material price fluctuations and changes in demand driven by economic cycles. Injecto Polymers, operating in this sector, could be exposed to such external market risks that might affect its financial performance.
Injecto Polymers IPO Details
| Company Name | Injecto Polymers |
|---|---|
| IPO Type | SME |
| Exchange | BSE |
| Price Band | ₹90 - ₹100 |
| Face Value | ₹10 per share |
| Lot Size | 1200 shares |
| Min Investment | ₹120,000 |
| Total Issue Size | ₹56.00 Cr |
|---|---|
| Fresh Issue | ₹56.12 Cr |
| Registrar | Integrated Registry Management Services Pvt.Ltd. |
| Lead Manager | Indcap Advisors Pvt.Ltd. |
| IPO Status | Open |
Injecto Polymers IPO Dates
Injecto Polymers IPO GMP Today
The Grey Market Premium (GMP) for Injecto Polymers IPO is not available.
Injecto Polymers IPO — Key Highlights
- Injecto Polymers is seeking to raise ₹56 Cr through a fresh issue IPO on the BSE SME platform.
- The company has reported a revenue of ₹261.85 Cr in its latest financial disclosures.
- The IPO's price band is set between ₹90 and ₹100 per share.
- The Earnings Per Share (EPS) for Injecto Polymers stands at ₹3.9.
- The P/E ratio for the IPO is approximately 25.64x at the upper price band.
- The lot size for retail investors is fixed at 1200 shares.
Injecto Polymers Financial Performance
| Revenue | ₹261.85 Cr |
|---|---|
| PAT | ₹8.11 Cr |
| EPS | ₹3.90 |
Injecto Polymers IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹3.90 |
|---|---|
| P/E Ratio | 25.64x |
| Debt/Equity | 0.000 |
Return Metrics
Injecto Polymers IPO Reservation / Allocation
Injecto Polymers IPO Lead Manager & Registrar
Book Running Lead Manager
Indcap Advisors Pvt.Ltd.
IPO Registrar
Integrated Registry Management Services Pvt.Ltd.
Injecto Polymers IPO — Frequently Asked Questions
What is Injecto Polymers IPO GMP today?
As of today, the Grey Market Premium (GMP) for Injecto Polymers IPO is not available at this time. GMP values are updated daily based on grey market activity.
What is the price band and lot size of Injecto Polymers IPO?
Injecto Polymers IPO has a price band of ₹90 to ₹100 per equity share with a face value of ₹10. The minimum lot size is 1200 shares, requiring a minimum investment of ₹120,000 at the upper band.
What are the important dates for Injecto Polymers IPO?
Injecto Polymers IPO opens for subscription on 11 Sep 2026 and closes on 16 Sep 2026. Allotment is expected on 17 Sep 2026. The shares are expected to list on BSE on 21 Sep 2026.
What is the investor category allocation in Injecto Polymers IPO?
The shares are reserved as follows — Qualified Institutional Buyers (QIB): 0.00%, Non-Institutional Investors (NII/HNI): 0.00%, and Retail Individual Investors: 35.04%.
How can I apply for Injecto Polymers IPO?
You can apply for Injecto Polymers IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is Integrated Registry Management Services Pvt.Ltd..
What is Injecto Polymers IPO price band and lot size?
The Injecto Polymers IPO has a price band set between ₹90 and ₹100 per share. Each lot consists of 1200 shares. Consequently, the minimum investment required to apply for this IPO is ₹120,000 (1200 shares x ₹100).
The face value of each share is ₹10.
Is Injecto Polymers IPO worth investing in?
Injecto Polymers presents a mixed picture with a decent revenue base of ₹261.85 Cr and an EPS of ₹3.9, but a relatively modest net profit margin. The P/E ratio of approximately 25.64x is not overly stretched but demands scrutiny given the margins.
On the plus side, it's a 100% fresh issue which means funds will fuel growth. However, the SME segment carries inherent risks. Investors need to weigh the potential for growth against these risks. You'll want to look closely at how they plan to use the ₹56 Cr raised. Investors should consult a SEBI-registered financial advisor before making investment decisions.
What is Injecto Polymers IPO GMP today?
Grey Market Premium (GMP) for the Injecto Polymers IPO is an unofficial indicator of demand. While it can provide a sense of market sentiment, it's important to remember that GMP is not a regulated figure. Any GMP observed, whether it's a positive ₹X or a negative ₹Y, should not be the sole basis for an investment decision.
It's a speculative market that can change rapidly.
How to apply for Injecto Polymers IPO?
You can apply for the Injecto Polymers IPO through either the UPI mechanism or the ASBA (Application Supported by Blocked Amount) facility. For UPI, you'll need to link your bank account to your demat account and approve the mandate via your UPI app. With ASBA, your application amount is blocked in your bank account until the allotment is finalized.
The registrar for this IPO is Integrated Registry Management Services Pvt.Ltd.